Interpreta, Inc., an analytics service company that delivers population and single-member analytics for precision medicine, will be exhibiting at HIMSS16 in Las Vegas from Feb. 29 – March 4.
Company representatives, including Chief Executive Officer Ahmed Ghouri, will demonstrate for health plans, accountable care organizations (ACOs) and integrated health systems how daily re-computation of vital patient and population data, combined with genomic data, delivers actionable insights, helps tailor therapies and increases efficiencies in the payer system.
“Interpreta’s daily analysis of a patient’s clinical and genomic data identifies crucial healthcare interventions to be performed, and identifies the best care plan possible before compliance windows expire. These actionable insights reduce costs and increase quality measures,” says Ghouri. “Daily healthcare analytics also empower medical professionals to manage the continuum of healthcare by alerting providers to time-sensitive requirements that help avoid adverse future events. This significantly improves healthcare outcomes for patients.”
Healthcare organizations can achieve superior HEDIS (Healthcare Effectiveness Data and Information Set), P4P (Pay for Performance) and Risk Adjustment scores, and significantly enhance drug safety and quality of care performance through Interpreta’s subscription-based cloud computing service, using a single, unified, streamlined platform.
Interpreta differs from previous fourth-generation healthcare analytics companies in its ability to update a patient’s annual care plan and compliance record on a daily basis, operating on national populations or by single member. This helps to close gaps in care by eliminating the time-delayed rear-view analysis that is common in healthcare today, which only provides data on what has already occurred. Interpreta provides a forward-looking perspective in which intervention opportunities can be proactively planned within clinical workflow.
Interpreta was founded by Ahmed Ghouri, M.D., Gary Rayner and Raghu Sugavanam, three seasoned and successful technology entrepreneurs. Additional biographical details are available here. Their combined experience in clinical analytics, information technology and growth of profitable companies is generating substantial momentum among leading organizations in key healthcare verticals. Interpreta will be announcing major customers in the near future.
To set up a meeting with Interpreta at HIMSS16, contact Bonnie@clearpointagency.com.
About Interpreta, Inc.
Interpreta delivers on the promise of precision medicine today. Through daily re-computation of individual member clinical and full-sequence genomic data, Interpreta’s fifth-generation healthcare analytics provide a prospective clinical interpretation that enables true personalization of therapy, and prevents clinical gaps before they occur. Interpreta’s daily dynamic guidance, updated at the single-member level, maximizes quality scores, enables precision medicine, reduces medical costs and improves outcomes. See the daily difference at www.Interpreta.com. Twitter: @InterpretaInc
Bonnie Shaw, 760-230-2424